The BioIndustry Initiative

Issue | Obstacles | Q&A | Quick Facts | Legislation | Agreements | Talking Points | Recommendations

Back to WMD Reference Center

The Issue

After more than a decade of effort to eliminate an urgent threat to global security, both anecdotal and empirical indicators suggest that there is a continuing risk of "brain drain" proliferation from the states of the former Soviet Union (FSU). While proliferation threats emanate from across the spectrum of weapons of mass destruction (WMD) specialties, former biological weapons specialists pose a particular challenge owing to the inability of current regimes to detect and deter the development of weaponized pathogens.

Within the first year after the collapse of the USSR, life for its once privileged community of scientists, engineers and technicians was irrevocably altered. Tens of thousands lost their jobs or went months without a paycheck. Even the brightest scientists and engineers were forced to seek work where they could get it-whether driving taxi cabs or selling their talents to foreign governments or terrorist organizations.[1] It was estimated that the Soviets had employed some 65,000 specialists within a vast biological warfare complex.[2] Most were capable of spreading materials or sensitive information to hostile groups and states. The aging community of researchers that previously raised the most concern, however, does not represent the only threat. According to recent analyses, younger bioscientists in the states of the FSU who have modern laboratory skills and direct access to biological materials at the erstwhile weapons institutes, as well as strong financial ambitions, pose equally daunting challenges to international security. The states of the former Soviet Union present a unique proliferation challenge in that the same area of the world where the most developed capacities to weaponize pathogens resides is also one of the most isolated in terms of scientific exchange. While government and private sector researchers are well acquainted with research being conducted in other developing countries-including India-FSU labs remain by and large a black box for Western researchers.

In the early 1990s when the government in Moscow eliminated funding to the massive Soviet-developed bioresearch and weapons production capacity, the United States launched a series of "scientist redirection" programs designed to ensure that the intellectual resources within that research and production complex did not proliferate to rogue states and terrorist organizations. The BioIndustry Initiative (BII) at the US State Department is one of the newer programs to emerge in the post-Cold War and post-9/11 era of counterproliferation and counterterrorism efforts. BII was created by Congress after September 11, 2001 to engage the US biotech and pharmaceutical industries as potential employers of the biological sciences expertise residing in the states of the FSU.

The BioIndustry Initiative's mandate is focused solely on biological threats, and works toward the long-term transition of large-scale FSU biological weapons production facilities, their technology and associated expertise to viable commercial research and production institutions. It also seeks to partner US and former Soviet biological and chemical weapons scientists to develop and accelerate the production of vaccines for infectious diseases that affect the FSU and the world. BII aspires to engage specific institutes, assesses their core capabilities as well as the appropriate domestic and international market, and then pairs Russian laboratories with American researchers in both academic and industrial sectors. It is anticipated that in 2007, major commercial reconfiguration projects such as the dismantlement of BW production buildings and the development of an animal feed mill at a former bioweapons production facility in Georgia will come to fruition, thus testing the viability of the BII model.

The stated objective of all current programs focused on the nonproliferation of expertise is to permanently and sustainably redirect former WMD specialists. Unfortunately, none of the existing programs is systematically creating the new jobs necessary to sustainably engage weapons experts and thus achieve this objective. Each program, while temporarily engaging the target community, is struggling to develop models that will sustain activities beyond the Western funding horizon. Because BII remains a relatively new program, its efforts have yet to bear significant fruit; however, structural limitations will likely limit long-term success due to its continued efforts to work within the walls of the erstwhile weapons institutes. The viability of the continuing focus on "conversion" of these institutes, in most instances, will not prove the most efficacious approach to creating sustainable job opportunities for the target population. At the very least, this approach is tremendously expensive. Inventive new models for effectively engaging and leveraging the talent resident in the WMD complexes in the region are overdue and must be developed.

BACK TO TOP


Obstacles

  • In the scheme of Cooperative Nonproliferation efforts, those focused on the human dimension, (i.e. proliferation of weapons know-how) are largely undervalued and face substantial difficulties in measuring their impact and gauging success.
  • There is a common perception on Capitol Hill that threat reduction programs have become welfare programs, rather than mutually beneficial programs necessary for US national security. This mistaken view of the US-FSU relationship has been a systematic impediment to achieving faster progress from the very beginning of cooperative nonproliferation efforts. Both the West and the states of the Former Soviet Union must take steps to reverse this belief.
  • While the BioIndustry Initiative (BII) was created to overcome the impediments rooted in the structure of the Science Centers, and to partner formally with industry to generate sustainable opportunities, BII has also confronted substantial limitations in its ability to systematically generate commercial opportunities for the bioscience community in the former weapons institutes. The focus on the institutes as the place of continuing employment for these scientists has created major impediments to industry's potential involvement in creating sustainable opportunities.

BACK TO TOP

 

Q & A

Q: What was the legacy of the complex of Soviet bioweapons institutes after the collapse of the Soviet Union?
A: It is estimated that the Soviets had employed some 65,000 specialists within a vast biological warfare complex.[3] Many were capable of spreading critical aspects of sensitive information to hostile groups and states. The retirement and death of many of these scientists has not reduced the threat, as a new generation with modern knowledge of and skills in the life sciences continue to look for sustainable employment.

Q: What are some of the obstacles to the success of BII and related scientist redirect efforts in general?
A: BII is a relatively new program, so its efforts have yet to bear significant fruit. However, structural limitations will limit long-term success due to its continued efforts to work within the walls of the erstwhile weapons institutes or convert them for commercial purposes. Overall, scientist redirect programming has been fairly successful at keeping former weapons scientists in place at their institutes and providing them short-term financial means to survive. However, efforts to find or generate sustainable, commercially-viable opportunities for the target communities have confronted insurmountable structural problems in terms of program management and funding streams. In addition, these programs have been subject to strained governmental relations and dwindling US political support or understanding of their potential value to US nonproliferation and foreign policy objectives.

Q: What are some alternative approaches for effectively engaging former BW scientists?
A: One alternative is to draw existing scientific capacity and expertise into a commercially viable enterprise outside of the weapons complexes. Short-term incentives could be used to engage private sector companies as employers. Additional incentives could be provided through collaboration with similar programs that stand to benefit from the sustainable employment of former BW specialists.

BACK TO TOP

 

Quick Facts

  • The Soviet Union is believed to have developed antibiotic-resistant strains of both tularemia and plague. [4] It is known that they had an overwhelming capability to undertake a strategic attack using plague or smallpox.
  • The Soviet military designated tularemia and Venezuelan equine encephalomyelitis as the principal agents for tactical or operational use on the battlefield. Anthrax and Marburg virus were nominated for attacking rear areas. A third category of agents comprised the highly transmissible agents smallpox and plague, which were categorized as strategic weapons and destined for use against enemy population centers.
  • A small airplane dispersing 220 pounds of anthrax spores could inflict more casualties in the Washington, DC metropolitan area than a missile carrying a hydrogen bomb.[5]
  • Biological agents may be the weapons of choice for terrorists because they are easily accessible (compared to nuclear materials), tracing the source of a disease outbreak can be extremely difficult, and many can be spread from person to person, causing an epidemic which can have severe social, psychological and political ramifications.

BACK TO TOP

 

Recent Legislation

  • N/A

BACK TO TOP

Applicable Treaties, Legislation, and Other International Agreements

  • The Defense Against Weapons of Mass Destruction Act of 1996 (Public Law 104-201, also known as the Nunn-Lugar-Domenici Act) outlined the threat posed by biological weapons and expanded the scope of Cooperative Nonproliferation programs.
  • Chapter 3 of Division B of the Department of Defense and Emergency Supplemental Appropriations for Recovery from and Response to Terrorist Attacks on the United States Act of Fiscal Year 2002 (Public Law 107-117) authorized the establishment of the BII.

BACK TO TOP

Talking Points

  • It is estimated that the Soviets had employed some 65,000 specialists within a vast biological warfare complex.
  • At the end of the Cold War, Moscow cut funding to its bioresearch and weapons programs. To stem "brain drain" proliferation, the US government launched a series of scientist redirection programs to keep scientists at work in their former institutes. This approach is not the most effective for preventing proliferation, as scientists are left isolated from the global research community and do not have sustained employment. New models are urgently needed.
  • The aging community of researchers that has previously raised the most concern does not represent the only human proliferation threat. Young FSU bioscientists with modern laboratory skills that have direct access to biological materials at the erstwhile weapons institutes, as well as strong financial ambitions, pose equally daunting challenges to international security.
  • By attempting to establish programs with commercial viability, the BII is attempting to ensure the long-term sustainability of the program.
  • BII has an Intellectual Property (IP) Support program that aims to bridge the gap between the program's laboratory research and commercially attractive deals.
  • BII's emphasis on working in the walls of former BW institutes will limit its long-term success and sustainability. Efforts to foster sustainable employment and project viability in the marketplace must extend beyond these boundaries.
  • BII is currently engaged with 38 different Russian institutions.[6]

BACK TO TOP

Recommendations

  • Since the introduction of the Cooperative Nonproliferation (CNP) programs in the early 1990s, there has not been a global reassessment of these programs' roles and objectives to ensure efficiency and effectiveness in the current strategic environment. A National Security Council designee should spearhead an interagency process to reassess the global role of CNP efforts in today's context, including those that have arisen in the past few years. Such a close examination of the entire suite of programs, including those that deal with biological weapons, across all relevant government agencies should strive to eliminate duplication, consolidate where necessary, and fill any gaps within the existing efforts.
    [See Book Recommendations #1 and #11]
  • Define goals for BW threat reduction and redirect programs in the context of each participating agency's objectives as well as within the long-term strategic objectives of the US Government's foreign policy. In addition, each agency's role and relationships must be clarified.
    [See Book Recommendations #2 and #16]
  • A reassessment of the prospects and pitfalls of US-Russian relations should be a fundamental component to a reevaluation of the suite of cooperative threat reduction programs, including those related to BW. Not only should the radically changed economic situation provide the context for a fresh look at US Government programs with Russia, but the analysis should include concrete measures for leveraging recent US-Russian agreements to begin the transition from "patronage to partnership."
    [See Book Recommendation #5]
  • A bicameral congressional task force should be created to regularly provide briefings from a broad array of the programs and actors involved in the actual implementation of biological weapons-related CNP activities. Such briefings would go a long way in creating the needed knowledge base on Capitol Hill.
    [See Book Recommendation #7]
  • The bioweapons-related scientific and technical talent resident in the WMD complexes in the states of the FSU must be effectively engaged and leveraged. This can be done by channeling government programs to meet mutually identified needs, as well as by undertaking a serious effort to create an appropriate incentive structure to engage potential employers, i.e. private industry actors. The emphasis of existing programs on scientific collaboration or technology development only too infrequently creates sustainable employment.
    [See Book Recommendations #8 and #23]
  • BII has confronted substantial limitations in its ability to systematically generate commercial opportunities for the bioscience community in erstwhile weapons institutes. The focus on the institutes as the place of continuing employment for these scientists would appear to create significant impediments to industry's potential involvement in creating sustainable opportunities. Similarly, while an emphasis on "conversion" of existing facilities may be valid in exceptional cases, this approach is tremendously expensive and may, in certain cases, be less efficacious than incentivizing green fields investments that would draw the scientific capacity into a commercially viable enterprise outside the weapons complex. BII should consider approaches that may enhance the probability of sustainable redirection.
    [See Book Recommendation #24]

BACK TO TOP    Back to WMD Reference Center 

 


Endnotes

[1] Ken Alibek, Biohazard (New York: Random House, 1999): 270-279.
[2] Amy E. Smithson, Toxic Archipelago: Preventing Proliferation from the former Soviet Chemical and Biological Weapons Complexes, (Washington: The Henry L. Stimson Center, 1999), accessed at: http://www.stimson.org/cbw/pdf/toxicarch.pdf.
[3] Ibid.
[4] Ken Alibek, "Behind the Mask: Biological Warfare" Perspective Vol. 9, No. 1 (Sept.-Oct. 1998), Institute for the Study of Conflict, Ideology, and Policy, accessed at: http://www.bu.edu/iscip/vol9/Alibek.html.
[5] Col. Jim Davis and Anna Johnson-Winegar, "The Anthrax Terror: DOD's Number-One Biological Threat" Aerospace Power Journal (Winter 2000), accessed at: http://www.airpower.maxwell.af.mil/airchronicles/apj/apj00/win00/davis.htm.
[6] BioIndustry Initiative, "Profiles of Russian Partner Institutions," accessed at: http://biistate.net/docs/profiles.php.

BACK TO TOP | Back to WMD Reference Center

 

Last Updated on May 30, 2007